Literature DB >> 10981157

The influence of national guidelines on antihypertensive prescribing patterns.

D Siegel1.   

Abstract

Efforts to influence medical practice include the formation of expert medical panels who make recommendations for the evaluation and treatment of clinical problems. Despite the considerable expense and effort that go into these activities, it is unclear whether they are successful. Recent studies have evaluated whether recommendations from the Fifth Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) published in 1993 influenced antihypertensive prescribing patterns. These included a national study of medications dispensed by retail pharmacies and an evaluation of antihypertensive prescribing patterns in US Veterans Affairs (VA) medical facilities. Despite recommendations from JNC V that hydrochlorothiazide and beta-blockers be used as first choice for most hypertensive patients, calcium antagonists and angiotensin converting enzyme (ACE) inhibitors were the most common drugs prescribed for hypertension in both 1992 (before JNC V) and 1995 (after JNC V). In retail pharmacies, changes in antihypertensive drug dispensing patterns from 1992 to 1995 reflected increased use of calcium antagonists and ACE inhibitors and decreased use of diuretics and beta-blockers, suggesting that JNC V recommendations had little effect on prescribing patterns. Similar patterns of antihypertensive drug use were found in VA facilities. The reasons for the lack of influence of JNC V recommendations on antihypertensive prescribing patterns must be explored and alternative ways of educating health care providers implemented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981157     DOI: 10.1007/s11906-000-0007-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  25 in total

1.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

2.  Is the calcium antagonist debate having an effect on clinical practice?

Authors:  F D Hobbs
Journal:  Am J Cardiol       Date:  1997-05-22       Impact factor: 2.778

Review 3.  Improving drug prescribing in primary care: a critical analysis of the experimental literature.

Authors:  S B Soumerai; T J McLaughlin; J Avorn
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

4.  Hypertension: steps forward and steps backward. The Joint National Committee fifth report.

Authors:  M A Weber; J H Laragh
Journal:  Arch Intern Med       Date:  1993-01-25

5.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

6.  National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.

Authors:  R S Stafford; D Saglam; D Blumenthal
Journal:  Arch Intern Med       Date:  1997-11-24

7.  Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996.

Authors:  D Siegel; J Lopez; J Meier
Journal:  Am J Hypertens       Date:  1998-11       Impact factor: 2.689

8.  Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. An effect of the major clinical trials on clinical practice?

Authors:  B M Psaty; T D Koepsell; N D Yanez; N L Smith; T A Manolio; S R Heckbert; N O Borhani; J M Gardin; J S Gottdiener; G H Rutan
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

9.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

10.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

View more
  4 in total

1.  Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan.

Authors:  Steven G Morgan
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

2.  Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010.

Authors:  Valy Fontil; Mark J Pletcher; Raman Khanna; David Guzman; Ronald Victor; Kirsten Bibbins-Domingo
Journal:  J Gen Intern Med       Date:  2013-11-19       Impact factor: 5.128

3.  Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Marty S Player; James M Gill; Heather Bittner Fagan; Arch G Mainous
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

4.  Clinical and nonclinical correlates of adherence to prescribing guidelines for hypertension in a large managed care organization.

Authors:  Philip C Skelding; Sumit R Majumdar; Ken Kleinman; Cheryl Warner; Susanne Salem-Schatz; Irina Miroshnik; Lisa Prosser; Steven R Simon
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.